U.S. flag

An official website of the United States government

NM_144599.5(NIPA1):c.134C>G (p.Thr45Arg) AND Hereditary spastic paraplegia 6

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002628.11

Allele description [Variation Report for NM_144599.5(NIPA1):c.134C>G (p.Thr45Arg)]

NM_144599.5(NIPA1):c.134C>G (p.Thr45Arg)

Genes:
LOC130056709:ATAC-STARR-seq lymphoblastoid silent region 6259 [Gene]
NIPA1:NIPA magnesium transporter 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q11.2
Genomic location:
Preferred name:
NM_144599.5(NIPA1):c.134C>G (p.Thr45Arg)
HGVS:
  • NC_000015.10:g.22786790C>G
  • NG_009056.1:g.5566C>G
  • NM_001142275.1:c.-48+542C>G
  • NM_144599.5:c.134C>GMANE SELECT
  • NP_653200.2:p.Thr45Arg
  • NC_000015.9:g.23086278G>C
  • NM_144599.4:c.134C>G
  • Q7RTP0:p.Thr45Arg
Protein change:
T45R; THR45ARG
Links:
UniProtKB: Q7RTP0#VAR_023440; OMIM: 608145.0001; dbSNP: rs104894496
NCBI 1000 Genomes Browser:
rs104894496
Molecular consequence:
  • NM_001142275.1:c.-48+542C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_144599.5:c.134C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary spastic paraplegia 6 (SPG6)
Synonyms:
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; Spastic paraplegia 6; Familial spastic paraplegia autosomal dominant 3
Identifiers:
MONDO: MONDO:0010878; MedGen: C1838192; Orphanet: 100988; OMIM: 600363

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022786OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2003)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV001406668Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 13, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q.

Fink JK, Wu CT, Jones SM, Sharp GB, Lange BM, Lesicki A, Reinglass T, Varvil T, Otterud B, Leppert M.

Am J Hum Genet. 1995 Jan;56(1):188-92.

PubMed [citation]
PMID:
7825577
PMCID:
PMC1801321

NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6).

Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK.

Am J Hum Genet. 2003 Oct;73(4):967-71. Epub 2003 Sep 23.

PubMed [citation]
PMID:
14508710
PMCID:
PMC1180617
See all PubMed Citations (6)

Details of each submission

From OMIM, SCV000022786.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In the large family with many members affected with autosomal dominant hereditary spastic paraplegia (SPG6; 600363) reported by Fink et al. (1995), Rainier et al. (2003) demonstrated a 159C-G transversion in NIPA1 cDNA, resulting in a thr45-to-arg (T45R) substitution. The same mutation was found in an unrelated kindred with autosomal dominant hereditary spastic paraplegia that was too small for meaningful linkage analysis.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001406668.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 45 of the NIPA1 protein (p.Thr45Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 14508710). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2520). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects NIPA1 function (PMID: 17166836, 19091982, 20816793). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024